EU starts real-time review of promising Sanofi-GSK COVID-19 vaccine

eu starts real time review of promising sanofi gsk covid 19 vaccine

Sumary of EU starts real-time review of promising Sanofi-GSK COVID-19 vaccine:

  • Issued on: 21/07/2021 – 08:31 Europe’s medicines agency announced on Tuesday it had began reviewing the COVID-19 vaccine developed by French pharmaceutical company Sanofi and Britain’s GlaxoSmithKline.
  • Advertising Read more The decision to start the “rolling review” of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early stage clinical trials in adults, the European Medicines Agency (EMA) said in a statement.
  • Late-stage global trials for the protein-based coronavirus vaccine candidate began in May.
  • Sanofi and GSK hope to get approvals by the end of 2021 after early-stage results showed the vaccine produces a robust immune response.

Other COVID-19 vaccine candidates in the EU’s rolling review are those from CureVac (Germany,) Novavax (US,) Sinovac (China) and Russia’s Sputnik V, developed by the Gamaleya Center of Epidemology and Microbiology in Moscow. 

Want to know more click here go to health news sourc

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.